Tower Research Capital LLC (Trc) Spruce Biosciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Spruce Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,650 shares of SPRB stock, worth $1,813. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,650
Previous 33,087
85.95%
Holding current value
$1,813
Previous $17,000
88.24%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SPRB
# of Institutions
34Shares Held
15.4MCall Options Held
16.7KPut Options Held
1.1K-
River Vest Venture Management LLC St. Louis, MO2.94MShares$1.15 Million20.39% of portfolio
-
Carlyle Group Inc. Washington, DC2.9MShares$1.13 Million0.2% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.61MShares$1.02 Million0.04% of portfolio
-
Abingworth LLP London, X01.79MShares$699,0820.65% of portfolio
-
Acadian Asset Management LLC Boston, MA1.26MShares$491,0680.0% of portfolio
About SPRUCE BIOSCIENCES, INC.
- Ticker SPRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 23,560,200
- Market Cap $9.19M
- Description
- Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...